International Partnership for Microbicides   Report issue

Academic/Hospital Phase 1 Phase 3
Founded: Silver Spring MD United States (2002)

Organization Overview

First Clinical Trial
2005
NCT00303576
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

International Partnership for Microbicides | International Pharmaceutical Research Center | IPM

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 2)

HIV Infections (Phase 3)

Immunologic Deficiency Syndromes (Phase 2)

Infections (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 19
  • # of Trial APIs: 8